Professor Linda Davies 

2011

• Morriss, R., Lobban, F., Jones, S., Riste, L., Peters, S., Roberts, C., Davies, L. & Mayes, D (2011). Pragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder. BMC Psychiatry, 11, 114. eScholarID:146023 | PMID:21777426 | DOI:10.1186/1471-244X-11-114

2010

• Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., Davies, L., Dunn, G., Eisner, E., Lewis, S., Moring, J., Steel, C. & Tarrier, N (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ, 341, c6325. eScholarID:146022 | PMID:21106618 | DOI:10.1136/bmj.c6325

2009

• Barrowclough, C, Haddock, G, Beardmore, R, Conrod, P, Craig, T, Davies, LM, Dunn, G, Lewis, S, Moring, J, Tarrier, N, Wykes, T. (2009). Evaluating integrated MI and CBT for people with psychosis and substance misuse: Recruitment, retention and sample characteristics of the MIDAS trial. Addict Behav, eScholarID:1d18984 | DOI:10.1016/j.addbeh.2009.03.007
• Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Farragher TM, Verstappen SS, Hassell A, Symmons D. (2009). Why do patients with inflammatory arthritis often score states "Worse than Death" on the EQ-5D? An investigation of the EQ-5D classification system. Value Health, [Epub ahead of print], eScholarID:1d19320 | DOI:10.1111/j.1524-4733.2009.00565.x
• O'Brien, K, Wright, J, Conboy, FM, Appelbe, PM, Davies, LM, Connolly, I, Mitchell, L, Littlewood, S, Mandall, N, Lewis, D, Sandler, J, Hammond, M, Chadwick, SM, O'Neill, J, McDade, C, Oskouei, M, Thiruvenkatachari, B, Read, M, Robinson, S, Birnie, D, Murray, A, Shaw, I, Harradine, N, Worthington, HV. (2009). Early treatment for Class II Division 1 malocclusion with the Twin-block appliance: a multi-center, randomized, controlled trial. Am J Orthod Dentofacial Orthop, 135( 5), 573-9. eScholarID:1d19355 | DOI:10.1016/j.ajodo.2007.10.042

2008

• Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons D. (2008). The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol, 35 (4), 592-602. eScholarID:1d17133
• Lovell, K, Bower, PJ, Richards, DA, Barkham, M, Sibbald, BS, Roberts, C, Davies, LM, Rogers, AE, Gellatly, JL, Hennessy, S. (2008). Developing guided self-help for depression using the Medical Research Council complex interventions framework: a description of the modelling phase and results of an exploratory randomised controlled trial. BMC Psychiatry, 8:91 (24 November 2008), eScholarID:1d18187 | DOI:10.1186/1471-244X-8-91
• McAllister MM, Payne K, Macleod R, Nicholls S, Dian Donnai, Davies LM. (2008). Patient empowerment in clinical genetics services. J Health Psychol, 13( 7), 895-905. eScholarID:1d17863 | DOI:10.1177/1359105308095063
• McAllister MM, Payne K, Macleod R, Stuart Nicholls, Donnai D, Davies LM. (2008). What process attributes of clinical genetics services could maximise patient benefits? Eur J Hum Genet, eScholarID:1d17868 | DOI:10.1038/ejhg.2008.121
• Payne K, Stuart Nicholls, McAllister MM, Macleod R, Donnai D, Davies LM. (2008). Outcome measurement in clinical genetics services: a systematic review of validated measures. Value in Health, 11, 497-508. eScholarID:1d17870 | DOI:10.1111/j.1524-4733.2007.00259.x
• Young AM, Temple B, Davies LM, Parkinson G, Bolton JE. (2008). Disabled children (0 to 3 years) and integrated services - the impact of Early Support. Health and Social Care in the Community, 16(3), 222-233. eScholarID:1d28150 | DOI:10.1111/j.1365-2524.2008.00765.x

2007

• Bamford, J, Fortnum, H, Bristow, K, Smith, J, Vamvakas, G, Davies, LM, Taylor, R, Watkin, P, Fonseca, S, Davis, A, Hind, S. (2007). Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen. Health Technol Assess, 11( 32), 1-168, iii-iv. eScholarID:1d31989
• Davies LM, Barnes TR, Jones PB, Lewis SW, Gaughran F, Hayhurst KP, Markwick A, Lloyd H. (2007). A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine. Value in Health, eScholarID:1d16840
• Davies LM, Fargher EA, Tricker K, Dawes P, Scott DL, Symmons D. (2007). Is shared care with annual hospital review better value for money than predominantly hospital based care in patients with established stable rheumatoid arthritis? Ann Rheum Dis, 66(5), 658-63. eScholarID:1d14283
• Davies LM, Lewis SW, Jones P, Barnes T, Gaughran F, Hayhurst KP, Markwick A, Lloyd H. (2007). Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. Br J Psychiatry, 191, eScholarID:1d15958
• McAllister MM, Payne K, Nicholls S, Macleod R, Donnai D, Davies LM. (2007). Improving Service Evaluation in Clinical Genetics: Identifying Effects of Genetic Diseases on Individuals and Families. J Genet Couns, Vol. 16(1), 71-83. eScholarID:1d15210
• Newman WG, Hamilton S, Ayres J, Sanghera N, Smith A, Gaunt L, Davies LM, Clayton-Smith J. (2007). Array comparative genomic hybridization for diagnosis of developmental delay: an exploratory cost-consequences analysis. Clin Genet, 71( 3), 254-9. eScholarID:1d15915
• Payne K, Nicholls SG, McAllister MM, Macleod R, Ellis I, Donnai D, Davies LM. (2007). Outcome measures for clinical genetics services: A comparison of genetics healthcare professionals and patients' views. Health Policy, doi: 10.1016/j.healthpol.2007.03.005, eScholarID:1d15913

2006

• Davies LM, Tamara Brown, Haynes S, Katherine Payne, Elliott RA, McCollum CN. (2006). Cost effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion. Health Technology Assessment. Health Technology Assessment, 10 (44), 1-228. eScholarID:1d13154
• Grill E, Uus K, Hessel F, Davies LM, Taylor RS, Wasem J, Bamford JM. (2006). Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screening. BMC Health Serv Res, 6( 1), eScholarID:1d12795
• Jones P, Barnes T, Davies LM, Dunn G, Lloyd H, Hayhurst K, Murray R, Markwick A, Lewis SW. (2006). Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry, 63( 10), 1079-87. eScholarID:1d14103 | DOI:10.1001/archpsyc.63.10.1079
• Lewis SW, Barnes TR, Davies LM, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB. (2006). Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia. Schizophr Bull, 32 (4), 715-23. eScholarID:1d13151 | DOI:10.1093/schbul/sbj067
• Lewis, SW, Davies, LM, Jones, P, Barnes, T, Murray, R, Kerwin, R, Taylor, DD.M., Hayhurst, KP, Markwick, A, Lloyd, H, Dunn, G. (2006). Randomised controlled trials of conventional antipsychotics versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technology Assessment, 10(17), eScholarID:1d12623
• McAllister MM, Payne K, Nicholls SSG, Macleod R, Donnai D, Davies LM. (2006). Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. Journal of Genetic Counselling, eScholarID:1d15517
• Payne K, Nicholls S, McAllister MM, Macleod R, Middleton-Price HH, Donnai D, Davies LM. (2006). Outcome measurement in clinical genetics services: a systematic review of validated measures. Journal Of Medical Genetics, 43 (supp 1), eScholarID:1d27975

2005

• Harrison, MJ, Tricker, K, Davies, LM, Hassell, A, Dawes, P, Scott, D, Knight, S, Davis, M, Mulherin, D, Symmons, D. (2005). The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol, 32( 12), 2330-6. eScholarID:1d13152
• Symmons D, Tricker K, Davies LM, Dawes P T, Scott D. (2005). The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technology Assessment, 9 (34), 1 - 94. eScholarID:1d12454

2004

• Davies LM, Payne K, Marion McAllister, Nicholls SSG, Macleod R, Middleton-Price HH, Donnai D. (2004). Developing appropriate models of service delivery in clinical genetics. Journal Of Medical Genetics, 41: supplement 1, eScholarID:1d28046